MDVLQ: AI 评分 50/100 — AI 分析 (4月 2026)

概要：

MDVLQ是做什么的？

MDVLQ的投资论点是什么？

MDVLQ在哪个行业运营？

MDVLQ有哪些增长机遇？

• Expansion of MedAvail MedCenters into Underserved Areas: MedAvail could have explored expanding its MedCenter kiosks into rural or underserved areas where access to traditional pharmacies is limited. This could have been achieved through partnerships with community health centers or mobile healthcare providers. The market size for rural healthcare is substantial, with ongoing efforts to improve access through telehealth and remote services. Timeline: 2-3 years for significant expansion.
• Integration with Telehealth Platforms: Integrating MedAvail's services with existing telehealth platforms could have provided a seamless experience for patients seeking remote consultations and prescription fulfillment. This would have required developing APIs and partnerships with telehealth providers. The telehealth market is projected to reach $55 billion by 2027, presenting a significant opportunity. Timeline: 1-2 years for initial integration.
• Partnerships with Employer-Sponsored Health Clinics: Collaborating with employers to install MedAvail MedCenters in on-site health clinics could have provided employees with convenient access to medications and pharmacist consultations. This would have required targeting large employers with a focus on employee wellness programs. The employer-sponsored health market is growing, driven by efforts to reduce healthcare costs and improve employee health. Timeline: 1-2 years for pilot programs.
• Development of a Mobile Pharmacy App: Creating a mobile app that allows patients to manage prescriptions, consult with pharmacists, and locate MedAvail MedCenters could have enhanced the company's digital presence and improved patient engagement. This would have required investing in app development and marketing. The mobile health market is expanding rapidly, with increasing adoption of digital health solutions. Timeline: 6-12 months for initial app launch.
• Expansion into Canada: Expanding its kiosk network into Canada could have provided access to a new market. This would have required navigating Canadian healthcare regulations and establishing partnerships with Canadian healthcare providers. The Canadian pharmacy retail market is substantial, with a growing demand for convenient and accessible pharmacy services. Timeline: 2-3 years for initial expansion.

• Market capitalization of $0.00B, reflecting the company's distressed financial state and Chapter 7 liquidation.
• Profit margin of -106.2%, indicating significant losses relative to revenue.
• Gross margin of 5.2%, suggesting limited profitability even before considering operating expenses.
• Return on Equity (ROE) of -194.7%, highlighting the company's inability to generate profits from shareholder equity.
• Debt-to-Equity ratio of 9.82, signaling a high level of financial leverage.

MDVLQ提供哪些产品和服务？

• Developed and commercialized self-service pharmacy kiosks (MedAvail MedCenters).
• Offered on-site prescription dispensing in various locations.
• Established audiovisual connections to live pharmacists for remote consultations.
• Provided a mobile application for managing prescriptions.
• Aimed to improve medication access and adherence.
• Served patients in the United States and Canada.

MDVLQ如何赚钱？

• Generated revenue through the dispensing of prescription medications via its MedAvail MedCenters.
• Charged fees for pharmacist consultations and related services.
• Established partnerships with medical clinics, retail stores, and employer sites to host MedAvail MedCenters.
• Focused on improving medication access and adherence for patients.

• Patients seeking convenient access to prescription medications.
• Medical clinics and healthcare providers looking to offer on-site pharmacy services.
• Retail stores and employer sites seeking to enhance customer and employee benefits.
• Individuals in the United States and Canada.

• Proprietary MedAvail MedCenter technology.
• Established network of partnerships with medical clinics, retail stores, and employer sites.
• First-mover advantage in the self-service pharmacy kiosk market.
• Integration of remote pharmacist consultations with on-site dispensing.

什么因素可能推动MDVLQ股价上涨？

• Ongoing: Bankruptcy proceedings and asset liquidation.

MDVLQ的主要风险是什么？

• Ongoing: Complete loss of investment due to liquidation.
• Potential: Legal challenges or claims arising from the bankruptcy proceedings.
• Potential: Delisting from the OTC market.

MDVLQ的核心优势是什么？

• Innovative self-service pharmacy kiosk technology.
• Remote pharmacist consultation capabilities.
• Potential for improved medication access and adherence.
• Strategic partnerships with medical clinics and retail locations.

MDVLQ的劣势是什么？

• High capital expenditure for kiosk deployment.
• Regulatory hurdles and licensing requirements.
• Limited brand recognition and market share.
• Dependence on partnerships for kiosk placement.

MDVLQ有哪些机遇？

• Expansion into underserved areas with limited pharmacy access.
• Integration with telehealth platforms and remote patient monitoring systems.
• Partnerships with employer-sponsored health clinics.
• Development of a mobile pharmacy app for enhanced patient engagement.

MDVLQ面临哪些威胁？

• Competition from established pharmacy chains and online pharmacies.
• Changes in healthcare regulations and reimbursement policies.
• Technological obsolescence and the emergence of new pharmacy solutions.
• Cybersecurity risks and data privacy concerns.

MDVLQ的竞争对手是谁？

• Walgreens Boots Alliance — Large established pharmacy chain with a broad retail presence. — (WBA)
• CVS Health Corporation — Integrated healthcare company with a large pharmacy network and health insurance business. — (CVS)

Key Metrics

• MoonshotScore: 50/100

Company Profile

• Headquarters: Phoenix, United States
• Employees: 279

AI Insight

• OTC Tier: OTC Other
• Disclosure Status: Unknown